SLC5A2 and type 2 diabetes mellitus: This cohort study examines the association of sodium-glucose cotransporter 2 vs dipeptidyl peptidase-4 inhibitor use with the incidence of obstructive airway disease and exacerbation events in patients with type 2 diabetes.